CLINICAL CHARACTERISTICS OF PATIENTS AFFECTED BY HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION AND UNDERGOING SGLT2I THERAPY

被引：0
|
作者：
Alcidi, G.
Pugliese, R.
Ioannoni, S.
Romano, M.
Granatiero, M.
Diomede, D.
Benvenuto, M.
Correale, M.
Brunetti, N.
Gronda, E.
Iacoviello, M.
机构：
[1] AOU Policlin Foggia, SC Cardiol, Foggia, Italy
[2] Area Cardiorenale & Metabol ANMCO, Teramo, Italy
[3] Area Cardiorenale & Metabol ANMCO, Milan, Italy
[4] AOU Policlin Foggia, Area Cardiorenale & Metabol ANMCO, SC Cardiol, Foggia, Italy
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P468
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Impact of SGLT2 inhibitors on cardiovascular outcomes in patients with heart failure with reduced ejection fraction
    Starr, Jessica A.
    Pinner, Nathan A.
    Lisenby, Katelin M.
    Osmonson, Alyssa
    PHARMACOTHERAPY, 2021, 41 (06): : 526 - 536
  • [22] SGLT2 inhibitors in heart failure with reduced ejection fraction
    Das, Uday Sankar
    Paul, Aritra
    Banerjee, Suvro
    EGYPTIAN HEART JOURNAL, 2021, 73 (01):
  • [23] SGLT2 inhibitors in heart failure with reduced ejection fraction
    Uday Sankar Das
    Aritra Paul
    Suvro Banerjee
    The Egyptian Heart Journal, 73
  • [24] Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction
    Zile, Michael R.
    Lindenfeld, Joann
    Weaver, Fred A.
    Zannad, Faiez
    Galle, Elizabeth
    Rogers, Tyson
    Abraham, William T.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (01) : 1 - 13
  • [25] Baroreflex activation therapy in patients with heart failure and reduced ejection fraction
    Clemencia, David Cordero
    Panadero, Clemencia de Rueda
    Baguda, Javier de Juan
    Bueno, Manuel Gomez
    Robles-Mezcua, Ainhoa
    Alvarez-Garcia, Jesu
    REVISTA ESPANOLA DE CARDIOLOGIA, 2024, 77 (04):
  • [26] Epidemiology and clinical characteristics of hospitalized patients with heart failure with reduced, mildly reduced, and preserved ejection fraction
    Rywik, Tomasz M.
    Dorynska, Agnieszka
    Wisniewska, Anna
    Ceglowska, Urszula
    Drohomirecka, Anna
    Topor-Madry, Roman
    Lazarczyk, Hubert
    Polaska, Paula
    Leszek, Przemyslaw
    Zielinski, Tomasz
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2022, 132 (05):
  • [27] Baroreflex Activation Therapy in Patients with Heart Failure with a Reduced Ejection Fraction
    Ruddy, Jean M.
    Kroman, Anne
    Baicu, Catalin F.
    Zile, Michael R.
    HEART FAILURE CLINICS, 2024, 20 (01) : 39 - 50
  • [28] Clinical Course of Patients With Worsening Heart Failure With Reduced Ejection Fraction
    Butler, Javed
    Yang, Mei
    Manzi, Massimiliano Alfonzo
    Hess, Gregory P.
    Patel, Mahesh J.
    Rhodes, Thomas
    Givertz, Michael M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (08) : 935 - 944
  • [29] Characteristics and Clinical Outcomes in Patients With Heart Failure With Preserved Ejection Fraction Compared to Heart Failure With Reduced Ejection Fraction: Insights From the VCOR Heart Failure Snapshot
    Tan, Christianne
    Diem Dinh
    Brennan, Angela
    Hare, David L.
    Kaye, David
    Lefkovits, Jeffrey
    Lockwood, Siobhan
    Neil, Christopher
    Prior, David
    Nasis, Arthur
    Wilson, Andrew
    Reid, Christopher M.
    Stub, Dion
    Driscoll, Andrea
    HEART LUNG AND CIRCULATION, 2022, 31 (05): : 623 - 628
  • [30] Clinical characteristics and prognosis of patients with heart failure and preserved or reduced left ventricular ejection fraction
    González-Juanatey, JR
    Varela, A
    Basanta, R
    Acuña, JMG
    Virgos, A
    Otero, IG
    Mazón, P
    EUROPEAN HEART JOURNAL, 2002, 23 : 82 - 82
12345